What proportion of initially prescribed antidepressants is still being prescribed chronically after 5 years in general practice? A longitudinal cohort analysis
Open accessThe DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.
Abstract
Objectives: Antidepressant prescribing almost doubled in the Netherlands between 1996 and 2012, which could be accounted for by longer continuation after the first prescription. This might be problematic given a growing concern of large-scale antidepressant dependence. We aimed to assess the extent and determinants of chronic antidepressant prescribing among patient aged 18 years and older. We hypothesise a relatively large prevalence of chronic (>2 years) prescription. Design: A longitudinal observational study based on routinely registered prescription data from general practice. Setting: 189 general practices in the Netherlands. Participants: 326 025 patients with valid prescription data for all 5 years of the study. Outcome measures: Primary outcome measure: the number of patients (N) receiving at least four antidepressant prescriptions in 2011, as well as during each of the four subsequent years. Secondary outcome measure: the above, but specified for selective serotonin reuptake inhibitors and for tricyclic antidepressants. Results: Antidepressants were prescribed to almost 7% of our 326 025 participants each year. They were prescribed for depression (38%), anxiety (17%), other psychological disorders (20%) and non-psychological indications (25%). Antidepressants were prescribed in all 5 years to the 42% of the population who had at least four prescriptions dispensed in 2011. Chronic prescribing was higher among women than men, for those aged 45–64 years than for those aged >65 years and for those treated for depression or anxiety than for non-psychological indications (eg, neuropathic pain). Chronic prescribing also varied markedly among general practices. Conclusion: Chronic antidepressant use is common for depression and for anxiety and non-psychological diagnoses. Once antidepressants have been prescribed, general practitioners and other prescribers should be aware of the risks associated with long-term use and should provide annual monitoring of the continued need for therapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Furthermore, research indicates that in the Netherlands, 75% of antidepressant indications are for depression, anxiety and other mental disorders and only 25% for non-mental indications, and that this 3:1 ratio increases further in the population with persistent use, as the majority in our sample. 33”
From Outcomes of hyperbolic tapering of antidepressants (2023) · cites this paper as [33]
In the citing paper
“Research further indicates that many people in receipt of long-term antidepressant medication do not necessarily require maintenance treatment.7,9,10”
From Protracted withdrawal syndrome after stopping antidepressants: a descriptive quantitative analysis of consumer narratives from a large internet forum (2020) · cites this paper as [10]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cipriani, A., Furukawa, T. A., Salanti, G., Chaimani, A., Atkinson, L. Z., Ogawa, Y., Leucht, S., Ruhe, H. G., Turner, E. H., Higgins, J. P. T., et al. (2018) · The Lancet · doi:10.1016/s0140-6736(17)32802-7 · Cited by 3,541
Kirsch, I., Deacon, B. J., Huedo-Medina, T. B., Scoboria, A., Moore, T. J., & Johnson, B. T. (2008) · PLoS Medicine · doi:10.1371/journal.pmed.0050045 · Cited by 2,442
International Classification of Primary Care
Bentsen, B. G. (1986) · Scandinavian Journal of Primary Health Care · doi:10.3109/02813438609013970 · Cited by 898
Antidepressant use and risk of adverse outcomes in older people: population based cohort study
Coupland, C., Dhiman, P., Morriss, R., Arthur, A., Barton, G., & Hippisley-Cox, J. (2011) · BMJ · doi:10.1136/bmj.d4551 · Cited by 833 · cited 2×
“26 27 A higher risk for falls, attempted suicides, stroke, fracture and epilepsy is reported for older people, using AD.”
ResultInfluences on antidepressant prescribing trends in the UK: 1995–2011
Mars, B., Heron, J., Kessler, D., Davies, N. M., Martin, R. M., Thomas, K. H., & Gunnell, D. (2017) · Social Psychiatry and Psychiatric Epidemiology · doi:10.1007/s00127-016-1306-4 · Cited by 419
Moore, M., Yuen, H. M., Dunn, N., Mullee, M. A., Maskell, J., & Kendrick, T. (2009) · BMJ · doi:10.1136/bmj.b3999 · Cited by 287
Mojtabai, R., & Olfson, M. (2014) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.13m08443 · Cited by 247
Wong, J., Motulsky, A., Abrahamowicz, M., Eguale, T., Buckeridge, D. L., & Tamblyn, R. (2017) · BMJ · doi:10.1136/bmj.j603 · Cited by 221
Cuijpers, P., van Straten, A., van Oppen, P., & Andersson, G. (2008) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v69n1102 · Cited by 219
Adult Utilization of Psychiatric Drugs and Differences by Sex, Age, and Race
Moore, T. J., & Mattison, D. R. (2017) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2016.7507 · Cited by 207 · cited 1×
“Based on evidence that they are more efficacious than placebo in adults with major depressive disorder,(1) antidepressants were used by more than 12% of the adult US population in 2013, with the prevalence in women being approximately double than in men, and increasing with age.(2) However, antidepressants are also pr…”
Background
Cited by
Prepandemic psychotropic drug status in Portugal: a nationwide pharmacoepidemiological profile
Madeira, L., Queiroz, G., & Henriques, R. (2023) · Scientific Reports · doi:10.1038/s41598-023-33765-0 · Cited by 143
“However, as observed in similar studies 23,24 , amitriptyline stands out in this scenario, probably, again, derived from its Federal Drug Association (FDA) non-approved use for the treatment of insomnia, chronic pain or bladder pain syndrome 25,26 .”
Hengartner, M. P., Schulthess, L., Sorensen, A., & Framer, A. (2020) · Therapeutic Advances in Psychopharmacology · doi:10.1177/2045125320980573 · Cited by 74
Hengartner, M. P. (2020) · Therapeutic Advances in Psychopharmacology · doi:10.1177/2045125320921694 · Cited by 72
Symptoms of anxiety and depression and risk of atrial fibrillation—The HUNT study
Feng, T., Malmo, V., Laugsand, L. E., Strand, L. B., Gustad, L. T., Ellekjær, H., Loennechen, J. P., Mukamal, K. J., & Janszky, I. (2019) · International Journal of Cardiology · doi:10.1016/j.ijcard.2019.11.107 · Cited by 65
“Another European study found that 25% of prescribed antidepressants were used for chronic pain [25].”
BackgroundExploration of GP perspectives on deprescribing antidepressants: a qualitative study
Kelly, D., Graffi, J., Noonan, M., Green, P., Mcfarland, J. W., Hayes, P., & Glynn, L. G. (2021) · BMJ Open · doi:10.1136/bmjopen-2020-046054 · Cited by 36
Coe, A., Gunn, J. M., Fletcher, S. L., Murray, E., & Kaylor‐Hughes, C. (2023) · Primary Health Care Research & Development · doi:10.1017/s1463423623000038 · Cited by 24
“Evidence suggests that much of the increase in antidepressant use can be accounted for by long-term use ( > 2 years) (Mojtabai and Olfson, 2013; Verhaak et al ., 2019) rather than an increase in the incidence and prevalence of depression (Munoz-Arroyo et al ., 2006).”
Amrein, M. A., Hengartner, M. P., Näpflin, M., Farcher, R., & Huber, C. A. (2023) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-023-03559-4 · Cited by 23
“Several studies showed that longer use of AD increased in the last decade [15–17].”
BackgroundResultInfluentialOutcomes of hyperbolic tapering of antidepressants
van Os, J., & Groot, P. C. (2023) · Therapeutic Advances in Psychopharmacology · doi:10.1177/20451253231171518 · Cited by 22
Long‐term antidepressant use in a cohort of older people
O’Neill, A., Mcfarland, J. W., & Kelly, D. (2021) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.5518 · Cited by 21
Antidepressant prescribing patterns in Australia
Malhi, G. S., Acar, M., Kouhkamari, M. H., Chien, T. H., Juneja, P., Siva, S., & Baune, B. T. (2022) · BJPsych Open · doi:10.1192/bjo.2022.522 · Cited by 20
Scholten, W., Batelaan, N., & Van Balkom, A. (2020) · Therapeutic Advances in Psychopharmacology · doi:10.1177/2045125320933404 · Cited by 17
Endocrine disease history and the risk of postpartum depression
Rasmussen, M.-L. H., Poulsen, G., Videbech, P., Wohlfahrt, J., & Melbye, M. (2022) · The British Journal of Psychiatry · doi:10.1192/bjp.2022.173 · Cited by 16
Tratamento medicamentoso para depressão e prevenção quaternária
Pereira, M. T. C. G., de Souza, F. A. M., & Cardoso, F. M. (2021) · Revista Brasileira de Medicina de Família e Comunidade · doi:10.5712/rbmfc16(43)2568 · Cited by 15
Prescribing behavior of antidepressants for depressive disorders: A systematic review
Lam, M. K., Lam, L. T.-M., Butler-Henderson, K. A., King, J., Clark, T., Slocombe, P., Dimarco, K., & Cockshaw, W. D. (2022) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2022.918040 · Cited by 13
“(31) The Netherlands A secondary data analysis study 326,025 Adults, Long-term use, and bias in prescription”
MethodCherrie, M. P. C., Curtis, S. E., Baranyi, G., McTaggart, S., Cunningham, N., Licence, K. A. M., Dibben, C. J. L., Bambra, C. L., & Pearce, J. R. (2020) · BMC Psychiatry · doi:10.1186/s12888-020-02952-y · Cited by 13
Uso de antidepressivos e percepção de saúde entre adultos de 40 anos ou mais: estudo longitudinal.
Menolli, P. V. D. S., Garso, P. A. G., Guidoni, C. M., & Girotto, E. (2020) · Revista Colombiana de Ciencias Químico Farmacéuticas · doi:10.15446/rcciquifa.v49n1.85776 · Cited by 12
Spronk, I., van Baar, M. E., Verheij, R. A., Panneman, M. J. M., Dokter, J., Polinder, S., & Haagsma, J. A. (2023) · Archives of Public Health · doi:10.1186/s13690-022-01020-z · Cited by 12
Indications related to antidepressant prescribing in the Nivel-PCD database and the SIDIAP database
Camacho-Arteaga, L., Gardarsdóttir, H., Ibáñez, L., Souverein, P. C., van Dijk, L., Hek, K., Vidal, X., Ballarín, E., & Sabaté, M. (2022) · Journal of Affective Disorders · doi:10.1016/j.jad.2022.02.001 · Cited by 11
Coe, A., Gunn, J. M., & Kaylor‐Hughes, C. (2022) · JMIR Research Protocols · doi:10.2196/42526 · Cited by 10
“Other studies have shown that the prevalence of long-term use among antidepressant users is approximately 36% and 42% in the United Kingdom [9] and the Netherlands [10], respectively.”
BackgroundBrišnik, V., Rottenkolber, M., Vukas, J., Schechner, M., Lukaschek, K., Jung‐Sievers, C., Gensichen, J., Thiem, U., Drey, M., Krüger, N., et al. (2024) · BMC Medicine · doi:10.1186/s12916-024-03584-9 · Cited by 7
“However, longer than recommended use of antide-pressants is prevalent [5–9] and has been identified as a key driver for the global increase in antidepressant use [10, 11].”
BackgroundResultAntidepressants and Risk of Liver Cancer: A Systematic Review and Meta-Analysis
Chen, X., Wang, Y., Lu, T., Ao, Y., Wei, W., Duan, W., Li, H., & Guo, R. (2023) · Annals of Pharmacotherapy · doi:10.1177/10600280221143512 · Cited by 6
“5,7,9,47 In comparison with low dose ADs, high-dose subgroup had a lower risk of liver cancer.”
BackgroundAntidepressant deprescribing: State of the art and recommendations—A literature overview
Romagnoli, A., Zovi, A., Santoleri, F., & Lasala, R. (2024) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-023-03617-x · Cited by 6
“In recent years, the consumption of antidepressants has arisen, primarily due to the long-term use of these drugs rather than an increase in the incidence and prevalence of the condition [2].”
Familial risk of postpartum depression
Rasmussen, M.-L. H., Poulsen, G., Wohlfahrt, J., Videbech, P., & Melbye, M. (2022) · Acta Psychiatrica Scandinavica · doi:10.1111/acps.13465 · Cited by 4
Dewar-Haggart, R., Müller, I., Bishop, F. L., Geraghty, A. W. A., Stuart, B. L., & Kendrick, T. (2025) · PLoS ONE · doi:10.1371/journal.pone.0299676 · Cited by 3
Pharmacoepidemiology of antidepressants in the Russian Federation
Gomon, Y. М., Колбин, А. С., Анатольевна, Л. В., & Незнанов, Н. Г. (2025) · Real-World Data & Evidence · doi:10.37489/2782-3784-myrwd-068 · Cited by 3
Vittengl, J. R., Jarrett, R. B., Ro, E., & Clark, L. A. (2024) · International Journal of Risk & Safety in Medicine · doi:10.3233/jrs-230016 · Cited by 3
“Importantly, ADM effects are typically measured after weeks in RCTs [2,5], whereas community-dwelling adults often consume ADM for years [12,13].”
Movement Disorders Associated With SSRIs
Goldman, J. G., & Galicia, C. M. G. (2022) · Oxford University Press eBooks · doi:10.1093/med/9780197574317.003.0007 · Cited by 2
Brunn, M., Molinié, G., Padget, M., Dariel, O. P. D., & Zarca, K. (2024) · HAL · doi:10.13140/rg.2.2.11547.48169 · Cited by 2
The role of empathy in antidepressant withdrawal
van Schie, J., Lucassen, P. L., Birkenhäger, T. K., van Belkum, S. M., Bot, M., & Ligthart, S. A. (2025) · Therapeutic Advances in Psychopharmacology · doi:10.1177/20451253251397593 · Cited by 1
Mapping the evolution of the forced swim test across interpretation, welfare and pharmacology
Brandwein, C., Leenaars, C. H. C., Iorgu, A.-M., Becker, L., Pfeiffer, N., Vasilescu, A.-N., Cilurzo, C., Bleich, A., Talbot, S. R., Gass, P., et al. (2026) · Pharmacological Research · doi:10.1016/j.phrs.2026.108146 · Cited by 1
Factors associated with drug–drug interactions involving citalopram in the UK Biobank
Laplace, B., Wong, W. L. E., Menchetti, M., Ronchi, D. D., Fusar‐Poli, P., Fanelli, G., MNESYS – Mood and Psychosis Sub-Project (Spoke 5), Serretti, A., Lewis, C. M., & Fabbri, C. (2025) · BJPsych Open · doi:10.1192/bjo.2025.10060 · Cited by 1
Kaufmann, M., & Lehmann, P. (2019) · NeuroTransmitter · doi:10.1007/s15016-019-6915-1
The Use of Antidepressant Drugs in Climacteric Syndrome
Mendes, M. C., & de Sá, M. F. S. (2020) · Revista Brasileira Ginecologia e Obstetrícia · doi:10.1055/s-0040-1701457
Afbouwen van antidepressivaPreprint
Brouwer, S. (2022) · Authorea · doi:10.22541/au.164882447.77664965/v1
Afbouwen van antidepressivaPreprint
Brouwer, S. (2022) · Authorea · doi:10.22541/au.164882447.77664965/v2
Redican, E., McDowell, R. D., Rosato, M., Murphy, J., & Leavey, G. (2024) · Aging & Mental Health · doi:10.1080/13607863.2024.2387667
“There is some evidence of an increasing prevalence of long-term antidepressant medications (>5 years) (Verhaak et al., 2019), increasing the risk of side effects in older adults and mortality from prolonged use (Kendrick, 2021).”
Muhammed, O. S., Hassen, M., & Tages, H. (2024) · IJQHC Communications · doi:10.1093/ijcoms/lyae005
Li, P. (2026) · Health Economics · doi:10.2139/ssrn.5265767
Brišnik, V., Rottenkolber, M., Vukas, J., Schechner, M., Lukaschek, K., Jung-Sievers, C., Gensichen, J., Thiem, U., Drey, M., Krüger, N., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26981948
Brišnik, V., Rottenkolber, M., Vukas, J., Schechner, M., Lukaschek, K., Jung-Sievers, C., Gensichen, J., Thiem, U., Drey, M., Krüger, N., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26981954
Brišnik, V. (2025) · Electronic Theses of LMU Munich (Ludwig-Maximilians-Universität München) · doi:10.5282/edoc.35189
Brišnik, V., Rottenkolber, M., Vukas, J., Schechner, M., Lukaschek, K., Jung-Sievers, C., Gensichen, J., Thiem, U., Drey, M., Krüger, N., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26981951
Kaylor‐Hughes, C., Coe, A., Chondros, P., Densley, K., Fletcher, S. L., Chatterton, M. L., Hoyer, D., Chen, T. F., Ng, C. H., Mangin, D. A., et al. (2026) · JMIR Research Protocols · doi:10.2196/81858
Kulkarni, S., Prasad, D., Bauermeister, S., & Reinecke, A. (2026) · Translational Psychiatry · doi:10.1038/s41398-026-04176-2
Rennwald, A., Horowitz, M. A., Senn, O., Neuner-Jehle, S., & Hengartner, M. P. (2026) · Therapeutic Advances in Psychopharmacology · doi:10.1177/20451253261492597
Gradual Discontinuation of Citalopram After Decades of Maintenance Therapy: A Case Report
MS, B. P. D. M. (2026) · American Journal of Medical Case Reports · doi:10.12691/ajmcr-14-10-2
Lam, M. K., Lam, L. T., Butler-Henderson, K., King, J., Clark, T., Slocombe, P., Dimarco, K., & Cockshaw, W. (2022) · doi:10.3389/fpsyt.2022.918040.s001
Metadata
- Authors
- Verhaak, P. F. M., de Beurs, D., & Spreeuwenberg, P.
- Affiliations
- University Medical Center Groningen (NL)
- Netherlands Institute of Health Services Research (NIVEL), Utrecht, The Netherlands
- Netherlands Institute for Health Services Research (NL)
- Corresponding author
- Verhaak, Peter F M
- ORCID
- Verhaak, Peter F M
- Venue
- BMJ Open
- Publisher
- BMJ
- Published
- 2019-02
- Volume
- 9
- Issue
- 2
- Pages
- e024051
- ISSN
- 2044-6055 (ISSN-L)
- PMC
- PMC6377556
- OpenAlex
- W2913698857
- Cited by
- 45
- References
- 40
- Citations by year
- 2026: 3 · 2025: 5 · 2024: 7 · 2023: 8 · 2022: 10 · 2021: 3 · 2020: 7 · 2019: 2
- FWCI
- 6.91
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by-nc
- Locations
- BMJ Open (publishedVersion, cc-by-nc)
- Europe PMC (PubMed Central) (publishedVersion, other-oa)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- University of Groningen research database (University of Groningen / Centre for Information Technology) (publishedVersion, cc-by-nc)
- Data Archiving and Networked Services (DANS) (submittedVersion, other-oa)
- HighWire Press Open Archive (submittedVersion)
- University of Groningen research database (University of Groningen / Centre for Information Technology) (submittedVersion, cc-by-nc)
- Funders
- Nederlands Instituut voor Onderzoek van de Gezondheidszorg
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Mental Health Treatment and Access
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Health Sciences › Medicine › Geriatrics and Gerontology › Pharmaceutical Practices and Patient Outcomes
- Keywords
- antidepressant prescribing, long-term antidepressant use, selective serotonin reuptake inhibitors, tricyclic antidepressants, depression, anxiety, general practice, prescribing patterns, sex differences, age differences, clinical practice variation
- MeSH terms
- Adolescent, Adult, Age Factors, Aged, Antidepressive Agents, Anxiety, Depression, Female, Humans, Longitudinal Studies, Male, Middle Aged, Netherlands, Practice Patterns, Physicians', Drug Prescriptions, Sex Factors, Time Factors, Young Adult, General Practice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
